• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94151ED
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vascular System (Circulation), Impaired (2572)
Event Date 02/06/2020
Event Type  Injury  
Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional reported a ¿vascular event¿ and "post injection assessment blanching spot r nasal alar no cap refill" whilst treatment was being injected in the nasolabial folds and "nasal alar" with juvéderm® voluma® with lidocaine.Treatment is noted as "1500iu hylase in 5ml [illegible] nacl, with 30g & bd insulin syringe".Patient was also treated with warm compress, and aspirin.Event has resolved.
 
Event Description
Healthcare professional reported a ¿vascular event¿ and "post injection assessment blanching spot r nasal alar no cap refill" whilst treatment was being injected in the nasolabial folds and "nasal alar" with juvéderm® voluma® with lidocaine.Treatment is noted as "1500iu hylase in 5ml [illegible] nacl, with 30g & bd insulin syringe".Patient was also treated with warm compress, and aspirin.Event has resolved.
 
Manufacturer Narrative
Additional, corrected, and/or changed data: b.6., h.6.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA WITH LIDOCAINE 1ML
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
MDR Report Key9824465
MDR Text Key190316742
Report Number3005113652-2020-00114
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/12/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2020
Device Catalogue Number94151ED
Device Lot NumberVB20A90008
Was Device Available for Evaluation? No
Date Manufacturer Received03/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
TRANEXAMIC ACID, CHLORHEXIDINE.
Patient Outcome(s) Required Intervention;
Patient Age52 YR
-
-